Condition: Esophageal Cancer
Interventions: Radiation: Involved field irradiation; Radiation: Elective field irradiation; Drug: Paclitaxel; Drug: Lobaplatin; Drug: PEG-rhG-CSF
Sponsors: Chinese Academy of Medical Sciences; The First Affiliated Hospital with Nanjing Medical University; Tianjin Medical University Cancer Institute and Hospital; Anyang Cancer Hospital; Fujian Cancer Hospital; Beijing Cancer Hospital; Hebei Medical University Fourth Hospital
Recruiting
https://ift.tt/2PPJPHL
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου